The largest database of trusted experimental protocols

2 protocols using siva1 a01

1

Molecular Mechanisms of Autophagy Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CMV driven HA-ubiquitin and pSP65SRα-CagA plasmids have been described previously30 (link), 31 (link). pBABE-puro mCherry-EGFP-LC3B and pcDNA3-ARF constructs were purchased from Addgene (Cambridge, MA)32 (link).
siRNAs against p14ARF and TRIP12 were synthesized by Integrated DNA Technologies (Coralville, Iowa) using the following sequences 5′-CAUGGUGCGCAGGUUCUUGGUGACC-3′ and 5′-CCAGGAGCAACAACUGAAAUCUGCA-3′, respectively. The negative control (scrambled) siRNA was purchased from Ambion (Grand Island, NY).
Following primary antibodies were used in this research: rabbit monoclonal anti-p14ARF (clone EPR17878, ab185620) from Abcam (Cambridge, MA), mouse monoclonal anti-β-actin (clone AC-74) from Sigma (St. Louis, MO), mouse monoclonal anti-GFP from Vanderbilt Monoclonal Antibody Core (Nashville, TN), rabbit polyclonal anti-beclin-1 (#3738), anti-LC3B (#2775) from Cell Signaling (Danvers, MA), rabbit polyclonal anti-TRIP12 (A301-814A) and anti-MKRN1 (A300-990A) from Bethyl Laboratories (Montgomery, TX), rabbit polyclonal SIVA1 (A01) from Abnova (Walnut, CA). The secondary antibodies used were HRP-conjugated anti-mouse IgG from Promega and anti-rabbit IgG from Cell Signaling.
Proteasomal inhibitor MG132 was purchased from EMD Millipore (Burlington, MA). Cycloheximide, bafilomycin A, pepstatin A and E-64d were all from Sigma.
+ Open protocol
+ Expand
2

Molecular Mechanisms of Autophagy Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CMV driven HA-ubiquitin and pSP65SRα-CagA plasmids have been described previously30 (link), 31 (link). pBABE-puro mCherry-EGFP-LC3B and pcDNA3-ARF constructs were purchased from Addgene (Cambridge, MA)32 (link).
siRNAs against p14ARF and TRIP12 were synthesized by Integrated DNA Technologies (Coralville, Iowa) using the following sequences 5′-CAUGGUGCGCAGGUUCUUGGUGACC-3′ and 5′-CCAGGAGCAACAACUGAAAUCUGCA-3′, respectively. The negative control (scrambled) siRNA was purchased from Ambion (Grand Island, NY).
Following primary antibodies were used in this research: rabbit monoclonal anti-p14ARF (clone EPR17878, ab185620) from Abcam (Cambridge, MA), mouse monoclonal anti-β-actin (clone AC-74) from Sigma (St. Louis, MO), mouse monoclonal anti-GFP from Vanderbilt Monoclonal Antibody Core (Nashville, TN), rabbit polyclonal anti-beclin-1 (#3738), anti-LC3B (#2775) from Cell Signaling (Danvers, MA), rabbit polyclonal anti-TRIP12 (A301-814A) and anti-MKRN1 (A300-990A) from Bethyl Laboratories (Montgomery, TX), rabbit polyclonal SIVA1 (A01) from Abnova (Walnut, CA). The secondary antibodies used were HRP-conjugated anti-mouse IgG from Promega and anti-rabbit IgG from Cell Signaling.
Proteasomal inhibitor MG132 was purchased from EMD Millipore (Burlington, MA). Cycloheximide, bafilomycin A, pepstatin A and E-64d were all from Sigma.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!